Sequencing children’s tumor and normal tissue samples
Treatments studied
Part of Brain & nervous system, Cancer clinical trials.
This study collects children’s normal and tumor tissue (or blood-related normal samples) and reads their DNA/RNA to look at genetic information. It may help researchers understand cancer-related changes and improve future testing, even when the goal isn’t to treat you directly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a St. Jude patient with a diagnosed solid or liquid tumor (benign or malignant)
- Research staff need enough stored tissue to test—enough DNA and RNA from tumor and/or normal (if no tumor tissue is available, you can sometimes enroll with normal/germline sample only)
- You (or your legal guardian) must be willing and able to sign written informed consent
- You should not have had a prior bone marrow stem cell transplant (or a similar treatment that would make donor DNA not match your body)
- Your tissue samples must pass the study’s quality rules for testing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects and studies tissue or bone marrow samples from certain childhood tumors. The goal is to learn what’s going on inside the cancer (using molecular testing) to better understand the disease and how it may respond to treatment.
This study looks at genetic (DNA) differences to better understand why treatments work differently for children at St. Jude. It may help doctors choose safer or more effective treatments in the future.
This study looks at the DNA and other biology from skin lesions (like melanoma or unusual pigmented moles) in children and teens. It aims to better understand what these tumors are and how they behave, using tissue samples collected during routine care.
This study collects and stores tumor and blood samples from children and young adults with cancer, blood disorders, or immune conditions. The samples are used to better understand these diseases and could help future treatments.
This study collects tumor (or related) samples to analyze their genes and build a shared research “biobank.” It may help researchers understand cancers better for future diagnosis and treatments.
This trial studies how personalized (tailored) genetic testing can help guide care for children with cancer. It may help match treatment choices to each child’s genetic risk, and it includes optional return of germline (inherited) test results.
Hear when a new Solid, Liquid, Central Nervous System Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.